Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/05/052745
CTRI/2023/05/052745
Not yet recruiting
未知

A STUDY ON PREVALENCE OF PERIPHERAL NEUROPATHY IN TYPE 2 DIABETESMELLITUS AND ITS CORRELATION WITH HBA1C AND OTHER RISK FACTORS

DR LAKSHIKA SAINI0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Sponsor
DR LAKSHIKA SAINI
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
DR LAKSHIKA SAINI

Eligibility Criteria

Inclusion Criteria

  • •People diagnosed with type 2 diabetes mellitus with HbA1c criteria fulfilling the T2DM diagnosis (as blood sugar â??fasting/pp can vary due to multiple reasons among admitted patients with various diagnosis)

Exclusion Criteria

  • •1\. Type 1 diabetes mellitus patients
  • •2\. Pregnancy
  • •3\. Patients with other known causes of peripheral neuropathy such as alcoholic, uremia, tuberculosis, HIV etc.
  • •4\. Patients on certain drugs having peripheral neuropathy as established toxicity.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Questionnaire survey about peripheral neuropaty with HIV infected patientsHIV/AIDS
JPRN-UMIN000036713Asahikawa medical university203
Completed
Not Applicable
percentage of patients developing nerve pain after endoscopic thyroid surgery done with a particular approach
CTRI/2021/03/031819Sanjay Kumar15
Active, not recruiting
Phase 1
A study to look at the long-term effects of droxidopa treatment in patients who experience low blood pressure when changing their posture
EUCTR2013-005118-36-ITChelsea Therapeutics, Incorporated450
Active, not recruiting
Phase 1
A study to look at the long-term effects of droxidopa treatment in patients who experience low blood pressure when changing their posture
EUCTR2013-005118-36-ESChelsea Therapeutics, Incorporated450
Recruiting
Not Applicable
Study on the pathophysiology of neuro-psychiatric disorders using a PET tracer ([18F]BCPP-EF)Dementia, Mild cognitive impairment, psychiatric disorders
JPRN-UMIN000036252Department of Biofunctional Imaging, Hamamatsu University School of Medicine60